PISCITELLI DOMINIC (Chief Financial Officer) sold 32.9% of their position (33.50K shares) of ORIC PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $351.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/24/2025ACC: 0001415889-25-018128
Officer· Chief Financial Officer
Since Apr 2020
-33.50K
Net shares
Net seller
$351.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
33.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−584.00
Price / share
$10.00
Trade value
$5.84K
% of position
0.6%
6/23/2025
101.82K→101.23K
Common Stock
Direct
Shares
−450.00
Price / share
$10.01
Trade value
$4.50K
% of position
0.4%
6/23/2025
101.23K→100.78K
Common Stock
Direct
Shares
−32.47K
Price / share
$10.50
Trade value
$341.04K
% of position
32.2%
6/24/2025
100.78K→68.32K
Total
Net shares
−33.50K
Net value
-$351.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2025 | S · Sale | −584.00 | $10.00 | $5.84K | 0.6% | 101.82K | 101.23K |
| Common Stock Direct | 6/23/2025 | S · Sale | −450.00 | $10.01 | $4.50K | 0.4% | 101.23K | 100.78K |
| Common Stock Direct | 6/24/2025 | S · Sale | −32.47K | $10.50 | $341.04K | 32.2% | 100.78K | 68.32K |
| Total | −33.50K | -$351.38K | ||||||
Derivative Transactions0
No derivative transactions reported